enalaprilat

出典: meddic

エナラプリラートエナラプリラト

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/08/05 23:59:11」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

英文文献

  • Targeting renin-angiotensin system in malignant hypertension in atypical hemolytic uremic syndrome.
  • Raghunathan V1, Sethi SK2, Dragon-Durey MA3, Dhaliwal M1, Raina R4, Jha P2, Bansal SB2, Kher V2.
  • Indian journal of nephrology.Indian J Nephrol.2017 Mar-Apr;27(2):136-140. doi: 10.4103/0971-4065.181462.
  • PMID 28356668
  • 99mTc-MAG3: Image Wisely.
  • Taylor AT1, Folks RD1, Rahman AK1, Polsani A1, Dubovsky EV1, Halkar R1, Manatunga A1.
  • Radiology.Radiology.2017 Feb 17:152311. doi: 10.1148/radiol.2017152311. [Epub ahead of print]
  • PMID 28212051
  • LC-MS/MS assay for quantitation of enalapril and enalaprilat in plasma for bioequivalence study in Indian subjects.
  • Halder D1, Dan S1, Pal MM2, Biswas E1, Chatterjee N2, Sarkar P1, Halder UC3, Pal TK1.
  • Future science OA.Future Sci OA.2017 Feb 2;3(1):FSO165. doi: 10.4155/fsoa-2016-0071. eCollection 2017.
  • PMID 28344828

和文文献

  • 銅及び亜鉛キレート形成によるangiotensin-converting enzyme(ACE)阻害剤エナラプリラトの脂溶性増加
  • 藤岡 晴人,稗田 雄三,倉本 康弘 [他],小西 華那世,木下(菊田) 恵美子,木下 英司,小池 透
  • 薬学雑誌. 乙号 133(10), 1135-1141, 2013
  • …   Enalaprilat (H2L), which is the active metabolite of the pro-drug enalapril, is an angiotensin-converting enzyme inhibitor. … For a better understanding of this phenomenon, we investigated the solution species of enalaprilat in the presence of copper(II) or zinc(II) ions by pH titration analysis with I=0.10 M (NaCl) at 25℃. …
  • NAID 130003361996
  • Simultaneous determination of enalapril and enalaprilat in human plasma by liquid chromatography-tandem mass spectrometry
  • GU Qi,CHEN Xiaoyan,ZHONG Dafang,WANG Yingwu
  • Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 813(1), 337-342, 2004-11-25
  • NAID 10016540865
  • Protective Effects of Quinaprilat and Trandolaprilat, Active Metabolites of Quinapril and Trandolapril, on Hemolysis Induced by Lysophosphatidylcholine in Human Erythrocytes
  • , , [他], , ,
  • Biological & pharmaceutical bulletin 26(5), 712-716, 2003-05-01
  • … We examined the effects of the angiotensin converting enzyme (ACE) inhibitors captopril, enalaprilat, quinapril, and trandolapril, and their active metabolites quinaprilat and trandolaprilat, on hemolysis induced by lysophosphatidylcholine (LPC) in human erythrocytes. …
  • NAID 110003608503

関連画像

living0life009Enalapril is currently administered in the Buy Enalaprilat Dihydrate | RAAS inhibitor Enalaprilat Injection USPEnalaprilat Injection, USP (1.25 mg/mL)Enalaprilat: Resealed erythrocytes: a


★リンクテーブル★
リンク元エナラプリラト」「エナラプリラート
関連記事enalapril

エナラプリラト」

  [★]

enalaprilat
エナラプリラート


エナラプリラート」

  [★]

enalaprilat
エナラプリラト


enalapril」

  [★] エナラプリル

WordNet   license wordnet

「an ACE inhibitor (trade name Vasotec) that blocks the formation of angiotensin in the kidney and so results in vasodilation; administered after heart attacks」
Vasotec




★コメント★

[メモ入力エリア]
※コメント5000文字まで
ニックネーム:
コメント:




表示
個人用ツール


  meddic.jp

リンク
連絡